William A. Robinson

15.2k total citations · 1 hit paper
373 papers, 10.6k citations indexed

About

William A. Robinson is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, William A. Robinson has authored 373 papers receiving a total of 10.6k indexed citations (citations by other indexed papers that have themselves been cited), including 140 papers in Oncology, 96 papers in Molecular Biology and 85 papers in Immunology. Recurrent topics in William A. Robinson's work include Cutaneous Melanoma Detection and Management (55 papers), Melanoma and MAPK Pathways (42 papers) and Immunotherapy and Immune Responses (40 papers). William A. Robinson is often cited by papers focused on Cutaneous Melanoma Detection and Management (55 papers), Melanoma and MAPK Pathways (42 papers) and Immunotherapy and Immune Responses (40 papers). William A. Robinson collaborates with scholars based in United States, Australia and United Kingdom. William A. Robinson's co-authors include Beverley L. Pike, René González, D Metcalf, T. R. Bradley, John E. Kurnick, Steven E. Robinson, Karl D. Lewis, Carol M. Amato, Martin D. McCarter and Aaron Liston and has published in prestigious journals such as Nature, New England Journal of Medicine and The Lancet.

In The Last Decade

William A. Robinson

357 papers receiving 9.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Human bone marrow colony growth in agar‐gel

1970 1.1k citations William A. Robinson et al. profile →

Peers

Countries citing papers authored by William A. Robinson

Since Specialization

Citations

This map shows the geographic impact of William A. Robinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William A. Robinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William A. Robinson more than expected).

Fields of papers citing papers by William A. Robinson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William A. Robinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William A. Robinson. The network helps show where William A. Robinson may publish in the future.

Co-authorship network of co-authors of William A. Robinson

This figure shows the co-authorship network connecting the top 25 collaborators of William A. Robinson. A scholar is included among the top collaborators of William A. Robinson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William A. Robinson. William A. Robinson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Routine Blood Glucose Monitoring Does Not Predict Onset of Immune Checkpoint Inhibitor–Induced Type 1 Diabetes 2024 ·Diabetes Care ·Halis Kaan Aktürk, (unknown), Kasey L. Couts, Kagan E. Karakus, William A. Robinson, Aaron W. Michels	3
2	SASH1 S519N Variant Links Skin Hyperpigmentation and Premature Hair Graying to Dysfunction of Melanocyte Lineage 2024 ·Journal of Investigative Dermatology ·(unknown), (unknown), Nabanita Mukherjee, Theresa Pacheco, (unknown), Morkos A. Henen, Beat Vögeli, Nathaniel B. Goldstein, Stanca A. Birlea, Jennifer D. Hintzsche, (unknown), Aik Choon Tan, Rui Zhao, David A. Norris, William A. Robinson, (unknown), (unknown), Yiqun G. Shellman	2
3	Targeting CDK4/6 Represents a Therapeutic Vulnerability in Acquired BRAF/MEK Inhibitor–Resistant Melanoma 2021 ·Molecular Cancer Therapeutics ·Kelsey W. Nassar, Jennifer D. Hintzsche, Stacey M. Bagby, (unknown), Christophe Langouët-Astrié, Carol M. Amato, Tugs‐Saikhan Chimed, Mayumi Fujita, William A. Robinson, Aik Choon Tan, Rebecca E. Schweppe	24
4	Safety and efficacy of avapritinib in advanced systemic mastocytosis: the phase 1 EXPLORER trial 2021 ·Nature Medicine ·Daniel J. DeAngelo, Deepti Radia, Tracy I. George, William A. Robinson, Albert Quiery, Mark W. Drummond, Prithviraj Bose, Elizabeth O. Hexner, Elliott F. Winton, Hans‐Peter Horny, Meera Tugnait, Oleg Schmidt-Kittler, Erica N Evans, Huimin Lin, Brenton G. Mar, Srđan Verstovšek, Michael W. Deininger, Jason Gotlib	88
5	Expression Differences in BCL2 Family Members between Uveal and Cutaneous Melanomas Account for Varying Sensitivity to BH3 Mimetics 2021 ·Journal of Investigative Dermatology ·Nabanita Mukherjee, (unknown), Carol M. Amato, (unknown), James R. Lambert, (unknown), William A. Robinson, Richard P. Tobin, Martin D. McCarter, Kasey L. Couts, Mayumi Fujita, David A. Norris, Yiqun G. Shellman	4
6	Melanocyte Precursors in the Hair Follicle Bulge of Repigmented Vitiligo Skin Are Controlled by RHO-GTPase, KCTD10, and CTNNB1 Signaling 2020 ·Journal of Investigative Dermatology ·Nathaniel B. Goldstein, Andrea Steel, (unknown), Maranke I. Koster, Michael Wright, Kenneth L. Jones, Bifeng Gao, Brian M. Ward, (unknown), (unknown), (unknown), Junxiao Hu, Caroline Lambert, Yiqun G. Shellman, Mayumi Fujita, William A. Robinson, Dennis R. Roop, David A. Norris, Stanca A. Birlea	15
7	CDK1 Interacts with Sox2 and Promotes Tumor Initiation in Human Melanoma 2018 ·Cancer Research ·Dinoop Ravindran Menon, Yuchun Luo, John J. Arcaroli, Sucai Liu, (unknown), Douglas G. Osborne, Yang Li, Jenny Mae Samson, Stacey M. Bagby, Aik Choon Tan, William A. Robinson, Wells A. Messersmith, Mayumi Fujita	100
8	Inhibition of MERTK Promotes Suppression of Tumor Growth in BRAF Mutant and BRAF Wild-Type Melanoma 2018 ·Molecular Cancer Therapeutics ·(unknown), Katherine A. Minson, John J. Tentler, (unknown), Stacey M. Bagby, William A. Robinson, (unknown), Tal Burstyn‐Cohen, S. Gail Eckhardt, Xiaodong Wang, Stephen V. Frye, H. Shelton Earp, Deborah DeRyckere, Douglas K. Graham	26
9	Avapritinib, a Potent and Selective Inhibitor of KIT D816V, Improves Symptoms of Advanced Systemic Mastocytosis (AdvSM): Analyses of Patient Reported Outcomes (PROs) from the Phase 1 (EXPLORER) Study Using the (AdvSM) Symptom Assessment Form (AdvSM-SAF), a New PRO Questionnaire for (AdvSM) 2018 ·Blood ·Jason Gotlib, Deepti Radia, Daniel J. DeAngelo, Prithviraj Bose, Mark W. Drummond, Elizabeth O. Hexner, William A. Robinson, Maureen G. Conlan, (unknown), Hongliang Shi, Michael W. Deininger	10
10	Fibroblast Subtypes Regulate Responsiveness of Luminal Breast Cancer to Estrogen 2016 ·Clinical Cancer Research ·Heather M. Brechbuhl, Jessica Finlay-Schultz, Tomomi M. Yamamoto, Austin E. Gillen, Diana M. Cittelly, Aik Choon Tan, Sharon B. Sams, Manoj M. Pillai, Anthony Elias, William A. Robinson, Carol A. Sartorius, Peter Kabos	164
11	CtBP1 Is Expressed in Melanoma and Represses the Transcription of p16INK4a and Brca1 2013 ·Journal of Investigative Dermatology ·Hui Deng, Jing Liu, Yu Deng, Gangwen Han, Yiqun G. Shellman, Steven E. Robinson, John J. Tentler, William A. Robinson, David A. Norris, Xiao‐Jing Wang, Qinghong Zhang	28
12	Recovery of MicroRNA from Stored Human Peripheral Blood Samples 2011 ·Biopreservation and Biobanking ·(unknown), Steven E. Robinson, Carol M. Amato, Lynne Bemis, William A. Robinson	5
13	Stereotactic Body Radiation Therapy for Melanoma and Renal Cell Carcinoma: Impact of Single Fraction Equivalent Dose on Local Control 2010 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), Brian D. Kavanagh, Tracey E. Schefter, René González, Thomas W. Flaig, Karl D. Lewis, William A. Robinson, Mark A. Chidel, Michael Glodé, David Raben	10
14	Blood-based biomarkers of malignant melanoma by gene expression analysis 2008 ·Journal of Investigative Dermatology ·(unknown), Jun‐ichi Fujita, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), William A. Robinson	1
15	A comparison of splinted and banded Herbst appliances: treatment changes and complications 2002 ·Australasian Orthodontic Journal ·Urban Hägg, (unknown), A. Bakr M. Rabie, William A. Robinson	22
16	Increased Survival of Patients Treated With a Vaccinia Melanoma Oncolysate Vaccine 1997 ·Annals of Surgery ·Marc K. Wallack, (unknown), (unknown), Palma M. Shaw, (unknown), Marshall M. Urist, Kirby I. Bland, D. Murray, William A. Robinson, Lawrence E. Flaherty, Jon Richards, Les Rosen, (unknown)	37
17	Human acquired nevi are clonal. 1996 ·Journal of Investigative Dermatology ·William A. Robinson, (unknown), Andrew G. Elefanty, (unknown)	5
18	A Compact Universal Power Supply for Laser Diodes. 1994 ·STIN ·Gary D. Noojin, Daniel X. Hammer, (unknown), William A. Robinson, (unknown)	0
19	Normal colony stimulating factor (CSF) production by bone marrow stromal cells and abnormal granulopoiesis with decreased CFUc in S1/S1d mice. 1976 ·PubMed ·(unknown), Bernd Hinrichs, W Fried, William A. Robinson, (unknown)	13
20	CYTOTOXINS RELEASED FROM PLASTIC PERFUSION APPARATUS 1968 ·The Lancet ·Robert C. Atkins, William A. Robinson, Ben Eiseman	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact